Jaguar Health (JAGX) Interest Coverage Ratio (2014 - 2026)
Jaguar Health's (JAGX) quarterly Interest Coverage Ratio came in at 5.9 in Q1 2026, up 134.23% year-on-year from 2.52 in Q1 2025, and up 101.44% on a QoQ basis from 408.5 in Q4 2025.
Jaguar Health (JAGX) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Interest Coverage Ratio data on file, last reported at 5.9 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 134.23% year-over-year to 5.9 in Q1 2026; TTM through Mar 2026 was 15.23, a 73.99% increase from a year earlier, with the FY2025 full-year figure at 25.18, down 7542.52% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 5.9, up from 408.5 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for JAGX reached as high as 74.15 in Q4 2024 and fell as low as 408.5 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 22.65 across 5 years, with a median of 3.62 in 2022.
- Across the five-year window, Interest Coverage Ratio jumped 6068.08% in 2024 and slumped 1064.63% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.49 in 2022, then plunged by 151.15% to 1.24 in 2023, then soared by 6068.08% to 74.15 in 2024, then plunged by 650.88% to 408.5 in 2025, then soared by 101.44% to 5.9 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 5.9 in Q1 2026, 408.5 in Q4 2025, and 3.97 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,810.93 Bn | 1,810.87 Bn | - | - |
| 2 | Akari Therapeutics | 997.56 Bn | 997.56 Bn | - | -157.58 |
| 3 | BeOne Medicines | 475.29 Bn | 470.50 Bn | 1.35 Bn | 7.60 |
| 4 | Vertex Pharmaceuticals | 124.40 Bn | 117.15 Bn | 2.59 Bn | 2.71 |
| 5 | Regeneron Pharmaceuticals | 72.15 Bn | 63.40 Bn | 3.31 Bn | 22.72 |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | -2.48 |
| 7 | Argenx Se | 54.26 Bn | 49.08 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.21 Bn | 35.20 Bn | 959.66 Mn | 3.88 |
| 9 | Revolution Medicines | 36.28 Bn | 36.28 Bn | - | -0.38 |
| 10 | Jaguar Health | 513,982.75 | -9.55 Mn | 19.11 Mn | 5.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.90 |
| Dec 31, 2025 | -408.50 |
| Sep 30, 2025 | -3.97 |
| Jun 30, 2025 | -3.84 |
| Mar 31, 2025 | -17.22 |
| Dec 31, 2024 | 74.15 |
| Sep 30, 2024 | -4.04 |
| Jun 30, 2024 | -3.90 |
| Mar 31, 2024 | -1.48 |
| Dec 31, 2023 | -1.24 |
| Sep 30, 2023 | -4.50 |
| Jun 30, 2023 | -2.35 |
| Mar 31, 2023 | -4.51 |
| Dec 31, 2022 | -0.49 |
| Sep 30, 2022 | -3.62 |
| Jun 30, 2022 | -2.55 |
| Mar 31, 2022 | -2.80 |
| Dec 31, 2021 | 3.50 |
| Sep 30, 2021 | -4.59 |
| Jun 30, 2021 | -5.76 |